Abstract

Background:In the clinical practice of Neoadjuvant chemotherapy, response markers are very important. We aimed

o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4

(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to

neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of Gastric cancer.

閱讀全文請見： Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy